Le Lézard
Classified in: Mining industry, Health, Science and technology, Business, Covid-19 virus
Subject: DIV

Avantor® Declares Dividend on Mandatory Convertible Preferred Stock


RADNOR, Pa., Jan. 21, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced today that its Board of Directors has declared a quarterly cash dividend of $0.78 per share to holders of its 6.250% Series A Mandatory Convertible Preferred Stock with a liquidation preference of $50, payable on February 15, 2022 to holders of record on February 1, 2022.

About Avantor
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. For more information, visit avantorsciences.com.

Forward-Looking and Cautionary Statements 
This press release contains, and oral statements made from time to time by Avantor's representatives may contain, "forward-looking statements." Forward-looking statements include statements regarding the proposed public offerings and other statements identified by words such as "could," "may," "might," "will," "likely," "anticipates," "intends," "plans," "seeks," "believes," "estimates," "expects," "continues," "projects" and similar references to future periods, or by the inclusion of forecasts or projections. Forward-looking statements are based on Avantor's current expectations and assumptions regarding capital market conditions, Avantor's business, the economy and other future conditions. Because forward-looking statements relate to the future, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. As a result, Avantor's actual results may differ materially from those contemplated by the forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements include the scale and scope of the COVID-19 pandemic; regional, national or global political, economic, business, competitive, market and regulatory conditions; Avantor's ability to anticipate consumer demand; changes in consumer confidence and spending; Avantor's competitive environment and other factors set forth under "Risk Factors" in Avantor's most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q. Any forward-looking statement made in this press release speaks only as of the date on which it is made. Avantor undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise.

Global Media Contact
Allison Hosak
Senior Vice President, Global Communications and Brand
Avantor
+1 908-329-7281
[email protected]

Investor Relations Contact
Tommy J. Thomas, CPA
Vice President, Investor Relations
Avantor
+1 781-375-8051
[email protected]

SOURCE Avantor and Financial News


These press releases may also interest you

at 07:35
ParTech, Inc. (PAR), a global restaurant technology company and provider of a unified commerce cloud platforms for enterprise restaurants, today announced that Snooze an A.M. Eatery has selected its leading Punchh, PAR's leading customer loyalty and...

at 07:35
Navidea Biopharmaceuticals, Inc. ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced acceptance of its abstract titled, "CD206 Targeted Delivery of...

at 07:35
Computer Services, Inc. (CSI) , a provider of end-to-end fintech and regtech solutions, signed 22 new community banks to its NuPoint® core platform during the past fiscal year, which ended Feb. 28, 2022. While each bank's decision was based on their...

at 07:30
Fennec Pharmaceuticals Inc. , a specialty pharmaceutical company focused on the development of PEDMARKTM (a unique formulation of sodium thiosulfate) for the prevention of platinum-induced ototoxicity in pediatric patients, today announced that the...

at 07:30
Mind Medicine (MindMed) Inc. , (NEO: MMED) (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, announced the appointment of Schond L. Greenway as Chief Financial Officer....

at 07:30
The Targeting Pods Market size is expected to reach USD 6026.4 million by 2027, registering to accelerate at a 6.5% CAGR, according to the most recent study by Brandessence Market Research & Consulting Pvt ltd. The Global Targeting Pods Market size...



News published on 21 january 2022 at 16:05 and distributed by: